CHINA PHARMA HOLDINGS, INC. (CPHI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 2M 4M 6M Q3 '16: 3.1M Q4 '16: 5.3M Q1 '17: 3.3M Q2 '17: 2.9M Q3 '17: 3.2M Q4 '17: 3.8M Q1 '18: 3.6M Q2 '18: 3.2M Q3 '18: 2.3M Q4 '18: 3.2M Q1 '19: 2.9M Q2 '19: 2.6M Q3 '19: 2.4M Q4 '19: 3M Q1 '20: 1.8M Q2 '20: 3.8M Q3 '20: 2.4M Q4 '20: 2.9M Q1 '21: 2.4M Q2 '21: 2.4M Q3 '21: 2M Q4 '21: 2.9M Q1 '22: 1.6M Q2 '22: 1.6M Q3 '22: 2M Q4 '22: 2.9M Q1 '23: 2M Q2 '23: 1.1M Q3 '23: 1.8M Q4 '23: 2.1M Q1 '24: 1.4M Q2 '24: 924.9K Q3 '24: 1.1M Q4 '24: 1.1M Q1 '25: 1.1M Q2 '25: 1M Q3 '25: 756.2K Q4 '25: 1.2M Q1 '26: 983.5K Q2 '26: 948.3K Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

-1.2M -600K 0 600K 1.2M 1.8M Q2 '16: 482.1K Q3 '16: 350K Q4 '16: 1.7M Q1 '17: 717.9K Q2 '17: 648.4K Q3 '17: 421.5K Q4 '17: 680.8K Q1 '18: 1.1M Q2 '18: 579.5K Q3 '18: 512.5K Q1 '19: 656.5K Q2 '19: 163.5K Q3 '19: 372.8K Q4 '19: 289.3K Q1 '20: 194.4K Q2 '20: 1.1M Q3 '20: 47.2K Q4 '20: 561.5K Q1 '21: 272.7K Q2 '21: 71K Q3 '21: -296.4K Q4 '21: 301.9K Q1 '22: -169.5K Q2 '22: -229.4K Q3 '22: -137.8K Q4 '22: 42.7K Q1 '23: 177.9K Q2 '23: -146.7K Q3 '23: -233.2K Q4 '23: -79.2K Q1 '24: -290K Q2 '24: -1M Q3 '24: -519.6K Q4 '24: -160.6K Q1 '25: -136.1K Q2 '25: -87K Q3 '25: -59.7K Q4 '25: 150.8K Q1 '26: 285.5K Q2 '26: 83.6K Q2 '17 Q3 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income Quarterly

-21M -14M -7M 0 7M 14M 21M Q3 '16: -1.5M Q4 '16: -3.1M Q1 '17: -802.6K Q2 '17: -2.1M Q3 '17: -2.1M Q4 '17: -13.7M Q1 '18: -140.7K Q2 '18: -864.4K Q3 '18: -1.9M Q4 '18: -7.5M Q1 '19: -334.2K Q2 '19: -753K Q3 '19: -645.2K Q4 '19: -18.7M Q1 '20: -599.3K Q2 '20: 75K Q3 '20: -952.5K Q4 '20: -1.1M Q1 '21: -696.5K Q2 '21: -752.9K Q3 '21: -762.4K Q4 '21: -648.7K Q1 '22: -911.7K Q2 '22: -779.6K Q3 '22: -688.7K Q4 '22: -1.2M Q1 '23: -397.5K Q2 '23: -456.3K Q3 '23: -713.5K Q4 '23: -1.2M Q1 '24: -916.1K Q2 '24: -1.4M Q3 '24: -1.1M Q4 '24: -1.2M Q1 '25: -758.6K Q2 '25: -652.1K Q3 '25: -628.1K Q4 '25: -1.2M Q1 '26: -1.1M Q2 '26: -1.4M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-21M -14M -7M 0 7M 14M 21M Q3 '16: -1.7M Q4 '16: -3.4M Q1 '17: -966.9K Q2 '17: -2.3M Q3 '17: -2.2M Q4 '17: -13.8M Q1 '18: -293.5K Q2 '18: -1M Q3 '18: -1.9M Q4 '18: -7.6M Q1 '19: -417.7K Q2 '19: -838.1K Q3 '19: -701K Q4 '19: -18.7M Q1 '20: -660.9K Q2 '20: 13.1K Q3 '20: -1M Q4 '20: -1.2M Q1 '21: -767.3K Q2 '21: -824.8K Q3 '21: -826.7K Q4 '21: -980.7K Q1 '22: -1M Q2 '22: -888.4K Q3 '22: -790.8K Q4 '22: -1.3M Q1 '23: -476K Q2 '23: -593K Q3 '23: -777.6K Q4 '23: -1.2M Q1 '24: -955.9K Q2 '24: -1.4M Q3 '24: -1.1M Q4 '24: -1.2M Q1 '25: -785.6K Q2 '25: -528.4K Q3 '25: -651.5K Q4 '25: -1.2M Q1 '26: -1.1M Q2 '26: -1.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 1.5M 3M 4.5M Q3 '16: 2.8M Q4 '16: 3.5M Q1 '17: 2.6M Q2 '17: 2.3M Q3 '17: 2.7M Q4 '17: 3.2M Q1 '18: 2.6M Q2 '18: 2.6M Q3 '18: 1.8M Q4 '18: 3.4M Q1 '19: 2.3M Q2 '19: 2.4M Q3 '19: 2M Q4 '19: 2.8M Q1 '20: 1.6M Q2 '20: 2.6M Q3 '20: 2.4M Q4 '20: 2.4M Q1 '21: 2.1M Q2 '21: 2.3M Q3 '21: 2.3M Q4 '21: 2.6M Q1 '22: 1.8M Q2 '22: 1.8M Q3 '22: 2.1M Q4 '22: 2.9M Q1 '23: 1.8M Q2 '23: 1.2M Q3 '23: 2M Q4 '23: 2.2M Q1 '24: 1.7M Q2 '24: 1.9M Q3 '24: 1.6M Q4 '24: 1.3M Q1 '25: 1.3M Q2 '25: 1.1M Q3 '25: 815.9K Q4 '25: 1.1M Q1 '26: 698K Q2 '26: 864.8K Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q2 '16: -748.3K Q3 '16: 866.8K Q4 '16: 1.5M Q1 '17: 9.8K Q2 '17: -783.3K Q3 '17: 678K Q4 '17: 936.8K Q1 '18: 523.7K Q2 '18: -399.3K Q3 '18: 883.3K Q4 '18: 874.4K Q1 '19: -236.5K Q2 '19: 386.6K Q3 '19: 480.2K Q4 '19: -22.1K Q1 '20: -244.2K Q2 '20: 91.4K Q3 '20: -224.4K Q4 '20: 334.9K Q1 '21: -276.9K Q2 '21: 676K Q3 '21: -450.8K Q4 '21: -198.1K Q1 '22: -879.4K Q2 '22: -333.8K Q3 '22: 219.1K Q4 '22: 584.6K Q1 '23: -1.5M Q2 '23: -216.4K Q3 '23: 1M Q4 '23: -22.3K Q1 '24: -585.2K Q2 '24: -72.7K Q3 '24: -47K Q1 '25: -73.7K Q2 '25: 274.3K Q3 '25: -204.4K Q4 '25: 152K Q1 '26: -55.3K Q2 '26: -32.8K Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-24M -16M -8M 0 8M 16M 24M Q2 '13: 3.2M Q3 '13: -8.7M Q4 '13: -23.2M Q1 '14: 2.5M Q2 '14: -77.1K Q3 '14: 182.6K Q4 '14: -1.6M Q1 '15: -49.3K Q2 '15: -731.2K Q3 '15: 1.1M Q4 '15: 1.7M Q1 '16: 1.3M Q2 '16: -853.8K Q3 '16: 846.7K Q4 '16: 1.4M Q1 '17: -16.9K Q2 '17: -808.5K Q3 '17: 662.5K Q4 '17: 867.6K Q1 '18: 520.1K Q2 '18: -425.7K Q3 '18: 879.9K Q4 '18: 856.6K Q1 '19: -310.3K Q2 '19: 386.3K Q3 '19: 468K Q4 '19: -72.4K Q1 '20: -592K Q2 '20: -401.2K Q3 '20: -483.8K Q3 '21: -866.8K Q4 '21: -205.2K Q1 '22: -880.8K Q2 '22: -509.1K Q3 '22: -33.4K Q3 '24: -56.2K Q1 '25: -132K Q2 '25: 274.2K Q3 '25: -205K Q4 '25: 151.5K Q2 '14 Q3 '15 Q4 '16 Q1 '18 Q2 '19 Q3 '20 Q3 '22 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q3 '11: 43.5M Q1 '12: 43.5M Q2 '12: 43.6M Q3 '12: 43.6M Q1 '13: 43.6M Q2 '13: 43.6M Q1 '15: 43.6M Q2 '15: 43.6M Q3 '15: 43.6M Q1 '16: 43.6M Q2 '16: 43.6M Q3 '16: 43.6M Q1 '21: 45.6M Q2 '21: 45.6M Q3 '21: 46M Q1 '22: 4.7M Q2 '22: 4.8M Q3 '22: 5M Q1 '23: 8.1M Q2 '23: 1.7M Q3 '23: 2.6M Q1 '24: 1.3M Q2 '24: 1.6M Q3 '24: 1.7M Q1 '25: 3.3M Q2 '25: 3.2M Q3 '25: 3.9M Q1 '26: 25.6M Q2 '26: 40.5M Q3 '11 Q1 '13 Q3 '15 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q3 '16: -0.28 Q4 '16: -0.22 Q1 '17: -0.20 Q2 '17: -0.19 Q3 '17: -0.20 Q4 '17: -0.43 Q1 '18: -0.42 Q2 '18: -0.39 Q3 '18: -0.38 Q4 '18: -0.25 Q1 '19: -0.25 Q2 '19: -0.25 Q3 '19: -0.23 Q4 '19: -0.49 Q1 '20: -0.50 Q2 '20: -0.48 Q3 '20: -0.48 Q4 '20: -0.07 Q1 '21: -0.07 Q2 '21: -0.09 Q3 '21: -0.09 Q4 '21: -0.75 Q1 '22: -0.95 Q2 '22: -1.11 Q3 '22: -1.25 Q4 '22: -3.78 Q1 '23: -3.62 Q2 '23: -3.79 Q3 '23: -3.92 Q4 '23: -0.72 Q1 '24: -1.38 Q2 '24: -1.92 Q3 '24: -2.28 Q4 '24: -2.72 Q1 '25: -2.24 Q2 '25: -1.51 Q3 '25: -1.03 Q4 '25: -0.74 Q1 '26: -0.54 Q2 '26: -0.42 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.